Farrow Jeffrey S bought TARS
June 15, 2026 · Form 4 insider transaction
Farrow Jeffrey S bought 27,881 shares of Tarsus Pharmaceuticals, Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
27,881
Price
N/A
Total value
N/A
InsiderFarrow Jeffrey S
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJune 15, 2026
Filing dateJune 17, 2026
Shares owned after71,197
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock.